GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tricida Inc (OTCPK:TCDAQ) » Definitions » Net Margin %

Tricida (Tricida) Net Margin % : 0.00% (As of Sep. 2022)


View and export this data going back to 2018. Start your Free Trial

What is Tricida Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Tricida's Net Income for the three months ended in Sep. 2022 was $-25.76 Mil. Tricida's Revenue for the three months ended in Sep. 2022 was $0.00 Mil. Therefore, Tricida's net margin for the quarter that ended in Sep. 2022 was 0.00%.

The historical rank and industry rank for Tricida's Net Margin % or its related term are showing as below:


TCDAQ's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -157.22
* Ranked among companies with meaningful Net Margin % only.

Tricida Net Margin % Historical Data

The historical data trend for Tricida's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tricida Net Margin % Chart

Tricida Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Net Margin %
Get a 7-Day Free Trial - - - - -

Tricida Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Tricida's Net Margin %

For the Biotechnology subindustry, Tricida's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tricida's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tricida's Net Margin % distribution charts can be found below:

* The bar in red indicates where Tricida's Net Margin % falls into.



Tricida Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Tricida's Net Margin for the fiscal year that ended in Dec. 2021 is calculated as

Net Margin=Net Income (A: Dec. 2021 )/Revenue (A: Dec. 2021 )
=-176.566/0
= %

Tricida's Net Margin for the quarter that ended in Sep. 2022 is calculated as

Net Margin=Net Income (Q: Sep. 2022 )/Revenue (Q: Sep. 2022 )
=-25.761/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tricida  (OTCPK:TCDAQ) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Tricida Net Margin % Related Terms

Thank you for viewing the detailed overview of Tricida's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Tricida (Tricida) Business Description

Traded in Other Exchanges
N/A
Address
7000 Shoreline Court, Suite 201, South San Francisco, CA, USA, 94080
Tricida Inc is a pharmaceutical company focused on the development and commercialization of its drug candidate, veverimer (TRC101), a non-absorbed, orally-administered polymer designed to treat metabolic acidosis by binding and removing acid from the gastrointestinal, or GI, tract. The primary area of focus is to slow the progression of chronic kidney disease through the treatment of metabolic acidosis.
Executives
David P Bonita director, 10 percent owner C/O ORBIMED ADVISORS LLC, 601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK NY 10022
Orbimed Advisors Llc director, 10 percent owner 601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK NY 10022
Robert J Alpern director YALE SCHOOL OF MEDICINE, 333 CEDAR STREET, C203 SHM, NEW HAVEN CT 06520
Venrock Healthcare Capital Partners Ii, L.p. 10 percent owner 7 BRYANT PARK, 23RD FLOOR, NEW YORK NY 10018
Sibling Capital Fund Ii-b L.p. 10 percent owner, other: *possible member of 10% group 2033 6TH AVE, SUITE 330, SEATTLE WA 98121
Sibling Capital Ventures Ii Llc 10 percent owner, other: *possible member of 10% group 2033 6TH AVE, SUITE 330, SEATTLE WA 98121
Brian M. Isern 10 percent owner, other: *possible member of 10% group 2033 6TH AVE., SUITE 330, SEATTLE WA 98121
Sibling Capital Fund Ii-c L.p. 10 percent owner, other: *possible member of 10% group 2033 6TH AVE, SUITE 330, SEATTLE WA 98121
Sibling Capital Ventures Iii Llc 10 percent owner, other: *possible member of 10% group 2033 6TH AVE, SUITE 330, SEATTLE WA 98121
Sibling Capital Fund Ii-a L.p. 10 percent owner, other: possible member of 10% group 500 YALE AVE N, SEATTLE WA 98109
Vhcp Management Eg, Llc 10 percent owner 3340 HILLVIEW AVENUE, PALO ALTO CA 94304
Venrock Healthcare Capital Partners Eg, L.p. 10 percent owner 3340 HILLVIEW AVENUE, PALO ALTO CA 94304
Vhcp Co-investment Holdings Iii, Llc 10 percent owner 7 BRYANT PARK, 23RD FLOOR, NEW YORK NY 10018
Vhcp Management Iii, Llc 10 percent owner 7 BRYANT PARK, 23RD FLOOR, NEW YORK NY 10018
Venrock Healthcare Capital Partners Iii, L.p. 10 percent owner 530 FIFTH AVENUE, 22ND FLOOR, NEW YORK NY 10036